BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peter J, Frey O, Stallmach A, Bruns T. Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes. BMC Gastroenterol. 2013;13:37. [PMID: 23446058 DOI: 10.1186/1471-230x-13-37] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2022;19:112-34. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
2 Rathod S. T cells in the peritoneum. International Review of Cell and Molecular Biology 2022. [DOI: 10.1016/bs.ircmb.2022.04.013] [Reference Citation Analysis]
3 Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S82-S100. [PMID: 34039494 DOI: 10.1016/j.jhep.2020.11.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
4 Singanayagam A, Triantafyllou E. Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting. Front Immunol 2021;12:661182. [PMID: 33868313 DOI: 10.3389/fimmu.2021.661182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
5 Lee DU, Fan GH, Hastie DJ, Prakasam VN, Addonizio EA, Ahern RR, Seog KJ, Karagozian R. The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data. J Clin Exp Hepatol 2021;11:531-43. [PMID: 34511813 DOI: 10.1016/j.jceh.2021.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
6 Bernsmeier C, van der Merwe S, Périanin A. Innate immune cells in cirrhosis. J Hepatol 2020;73:186-201. [PMID: 32240716 DOI: 10.1016/j.jhep.2020.03.027] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 19.3] [Reference Citation Analysis]
7 Zadka Ł, Grybowski DJ, Dzięgiel P. Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance. Cell Oncol (Dordr) 2020;43:539-75. [PMID: 32488850 DOI: 10.1007/s13402-020-00519-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang Z, Yang L, Ye J, Wang Y, Liu Y. Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia. Immunol Res 2019;67:373-81. [PMID: 31773491 DOI: 10.1007/s12026-019-09096-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ibidapo-Obe O, Stengel S, Köse-Vogel N, Quickert S, Reuken PA, Busch M, Bauer M, Stallmach A, Bruns T. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation. Cell Mol Gastroenterol Hepatol 2020;9:661-77. [PMID: 31954178 DOI: 10.1016/j.jcmgh.2020.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
10 Rigopoulou EI, Gershwin ME, Bogdanos DP. Immune Responses to Bacterial Infections. Liver Immunology 2020. [DOI: 10.1007/978-3-030-51709-0_12] [Reference Citation Analysis]
11 Irvine KM, Ratnasekera I, Powell EE, Hume DA. Causes and Consequences of Innate Immune Dysfunction in Cirrhosis. Front Immunol 2019;10:293. [PMID: 30873165 DOI: 10.3389/fimmu.2019.00293] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
12 Shirk EN, Kral BG, Gama L. Toll-like receptor 2bright cells identify circulating monocytes in human and non-human primates. Cytometry A 2017;91:364-71. [PMID: 28323396 DOI: 10.1002/cyto.a.23098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Silva PC, Silva AV, Silva TN, Vasconcelos LM, Gomes AV, Coêlho MR, Muniz MT, Domingues AL. There is no evident correlation between interleukin-10 gene polymorphisms and periportal fibrosis regression after specific treatment. Rev Soc Bras Med Trop 2016;49:781-5. [PMID: 28001230 DOI: 10.1590/0037-8682-0141-2016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Zimmermann HW, Trautwein C. Akut-auf-chronisches Leberversagen. Gastroenterologe 2016;11:28-33. [DOI: 10.1007/s11377-015-0032-x] [Reference Citation Analysis]
15 Moore JK, Mackinnon AC, Wojtacha D, Pope C, Fraser AR, Burgoyne P, Bailey L, Pass C, Atkinson A, Mcgowan NW. Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study. Cytotherapy. 2015;17:1604-1616. [PMID: 26342993 DOI: 10.1016/j.jcyt.2015.07.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
16 Santos CA, Brennan DC, Chapman WC, Fraser VJ, Olsen MA. Delayed-onset cytomegalovirus disease coded during hospital readmission in a multicenter, retrospective cohort of liver transplant recipients. Liver Transpl 2015;21:581-90. [PMID: 25678072 DOI: 10.1002/lt.24089] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
17 Nakamura I. Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids. World J Gastroenterol 2014; 20(23): 7298-7305 [PMID: 24966600 DOI: 10.3748/wjg.v20.i23.7298] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
18 Diao H, Cui G, Wei Y, Chen J, Zuo J, Cao H, Chen Y, Yao H, Tian Z, Li L. Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells. PLoS One 2014;9:e92823. [PMID: 24664315 DOI: 10.1371/journal.pone.0092823] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
19 Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(10): 2542-2554 [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 89] [Article Influence: 9.6] [Reference Citation Analysis]